Form 4: Alphatec Holdings COO Scott Lish Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Alphatec Holdings' Chief Operating Officer, Scott Lish, sold 23,183 shares of common stock on February 27, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 27, 2025, Scott Lish, the Chief Operating Officer of Alphatec Holdings, Inc. (ATEC), sold 23,183 shares of common stock.
- The sale was executed at a weighted average price of $12.03 per share, with individual transactions ranging from $10.79 to $12.57.
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 14, 2022, and amended on August 10, 2023.
- The purpose of the sale was to satisfy tax withholding obligations arising from the vesting of restricted stock units.
- Following the transaction, Lish directly owns 844,494 shares of Alphatec Holdings, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The sale is related to tax obligations and executed under a pre-arranged plan, suggesting no negative implications for the company's prospects.
Industry Context
Sales by company insiders are a common occurrence, often related to personal financial planning or tax obligations. The use of a pre-arranged 10b5-1 trading plan suggests the sale was planned in advance and not based on current market information.
Comparison to Industry Standards
- It's common for executives at publicly traded companies, such as Medtronic, Johnson & Johnson, and Stryker, to utilize 10b5-1 trading plans to manage their stock sales and avoid accusations of insider trading.
- The volume of shares sold is relatively small compared to the total outstanding shares of Alphatec Holdings, suggesting it's unlikely to have a significant impact on the stock price.
- Similar transactions are routinely disclosed by executives at comparable companies like NuVasive and Globus Medical.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, although the pre-arranged nature of the sale mitigates this concern.
- The impact on employees, customers, suppliers, and creditors is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 2022-12-14 | Date of adoption of Rule 10b5-1 trading plan. |
| 2023-08-10 | Date of amendment of Rule 10b5-1 trading plan. |
| 2025-02-27 | Date of stock sale transaction. |
| 2025-02-28 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.